Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Projan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Trends in Microbiology|October 16, 2002
Infectious diseases: back to the future?Paul Hagan, Steve Projan, John Rosamond
BMC Genomics|September 11, 2003
Increased retention of functional fusions to toxic genes in new two-hybrid libraries of the E. coli strain MG1655 and B. subtilis strain 168 genomes, prepared without passaging through E. coliSteven A Haney, David Keeney, Lei Chen, et al.
The Journal of Antibiotics|May 17, 2002
Identification of compounds that inhibit late steps of peptidoglycan synthesis in bacteriaMaureen DeCenzo, Mike Kuranda, Seth Cohen, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
In vitro and in vivo activities of novel 6-methylidene penems as beta-lactamase inhibitorsWilliam J Weiss, Peter J Petersen, Timothy M Murphy, et al.
The Lancet. Infectious Diseases|January 23, 2016
Alternatives to antibiotics-a pipeline portfolio reviewLloyd Czaplewski, Richard Bax, Martha Clokie, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Trends in Microbiology|October 16, 2002
Infectious diseases: back to the future?Paul Hagan, Steve Projan, John Rosamond
BMC Genomics|September 11, 2003
Increased retention of functional fusions to toxic genes in new two-hybrid libraries of the E. coli strain MG1655 and B. subtilis strain 168 genomes, prepared without passaging through E. coliSteven A Haney, David Keeney, Lei Chen, et al.
The Journal of Antibiotics|May 17, 2002
Identification of compounds that inhibit late steps of peptidoglycan synthesis in bacteriaMaureen DeCenzo, Mike Kuranda, Seth Cohen, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
In vitro and in vivo activities of novel 6-methylidene penems as beta-lactamase inhibitorsWilliam J Weiss, Peter J Petersen, Timothy M Murphy, et al.
The Lancet. Infectious Diseases|January 23, 2016
Alternatives to antibiotics-a pipeline portfolio reviewLloyd Czaplewski, Richard Bax, Martha Clokie, et al.
Pageof 1